Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis

Peritoneal Dialysis International

Volumn 26, Issue 5, 2006, Pages 574-580

  Ávila Díaz, Marcela ^a,d   Ventura, María de Jesús ^a   Valle, Delfilia ^a   Vicenté Martínez, Marlén ^b   García González, Zuzel ^b   Cisneros, Alejandra ^b   Furlong, María del Carmen ^c   Gómez, Ana María ^b   Prado Uribe, María del Carmen ^a   Amato, Dante ^a   Paniagua, Ramón ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c Hospital General de Zona IMSS   (Mexico)

^d NONE   (Mexico)

Author keywords

C reactive protein; End stage renal disease; Extracellular fluid volume; Inflammation; Sodium removal; Water removal

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; SERUM ALBUMIN; SODIUM; WATER;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL STUDY; CONTROLLED STUDY; DATA ANALYSIS; EXTRACELLULAR SPACE; FEMALE; FLUID INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PERITONEAL FLUID; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SODIUM INTAKE; STATISTICAL ANALYSIS; TOTAL BODY WATER; ULTRAFILTRATION;

EID: 33750554065     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600510     Document Type: Article

References (44)

1. Pecoits-Filho R, Stenvinkel P, Wang AY, Heimburger O, Lindholm B. Chronic inflammation in peritoneal dialysis: the search for the holy grail? Perit Dial Int 2004; 24: 327-39.
2. Chung SH, Heimburger O, Stenvinkel P, Qureshi AR, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 2003; 18:590-7.
3. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002; 13(Suppl 1):S28-36.
4. Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 2005; 67:2330-7.
5. Pecoits-Filho R, Araújo MRT, Lindholm B, Stenvinkel P, Abensur H, Romao JE Jr, et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17:1480-6.
6. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001; 59:407-14.
7. Chung SH, Heimbürger O, Stenvinkel P, Bergstrom J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 2001; 11:2240-5.
8. Chung SH, Heimburger O, Stenvinkel P, Wang T, Lindholm B. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int 2003; 23:174-83.
9. Paniagua R, Frías Y, Ventura MJ, Rodríguez E, Hurtado ME, Alcántara G, et al. C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis. Perit Dial Int 2003; 23:132-7.
10. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q. Infection, immunity, and atherosclerosis. Associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori and Cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000; 102:833-9.
11. Haubitz M, Brunkhorst R. C-reactive protein and chronic Chlamydia pneumoniae infection: long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 2001; 16:809-15.
12. Krediet RT, Ho-dac-Pannekeet MM, Struijk DG. Preservation of peritoneal membrane function. Kidney Int Suppl 1996; 56:S62-8.
13. Memoli B, Romano G, D'Arcangelo R, Del Prete M, Esposito P, Procino A, et al. The role of interleukin-6 and of its soluble receptors in the biocompatibility of dialysis treatment. Semin Nephrol 2004; 24:492-4.
14. Paniagua R, Ventura MJ, Rodríguez E, Sil J, Galindo T, Hurtado ME, et al. Impact of fill volume on peritoneal clearances and cytokine appearance in peritoneal dialysis. Perit Dial Int 2004; 24:156-62.
15. Vicenté-Martínez M, Martínez-Ramírez L, Muñoz R, Avila M, Ventura MJ, Rodríguez E, et al. Inflammation in patients on peritoneal dialysis is associated to increased extracellular fluid volume. Arch Med Res 2004; 35:220-4.
16. Kim SB, Chang JW, Lee SK, Park JS. Acute systemic inflammation is associated with an increase in peritoneal solute transport rate in chronic peritoneal dialysis patients. Perit Dial Int 2004; 24:597-600.
17. Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 2003; 18:797-803.
18. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.
19. Fine A. Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney Int 2002; 61:615-20.
20. Ohkuma T, Minagawa T, Takada N, Ohno M, Oda H, Ohashi H. C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am J Kidney Dis 2003; 42:355-61.
21. Nascimento MM, Pecoits-Filho R, Lindholm B, Riella MC, Stenvinkel P. Inflammation, malnutrition and atherosclerosis in end-stage renal disease: a global perspective. Blood Purif 2002; 20:454-8.
22. Su-Hernández L, Abascal-Macías A, Méndez-Bueno FJ, Amato D, Paniagua R. Epidemiologic and demographic aspects of peritoneal dialysis in México. Perit Dial Int 1996; 16:362-5.
23. Cueto-Manzano AM, Correa-Rotter R. Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 2000; 57:314-20.
24. Muñoz-de-Chávez M, Ledezma-Solano JA. Los alimentos y sus nutrientes. Tablas de Valor Nutritivo de Alimentos. México, D.F., México: McGraw Hill Interamericana, Health Care Group; 2002.
25. Twardowski ZJ. The fast peritoneal equilibration test. Semin Dial 1990; 3:141-2.
26. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107:499-511.
27. Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G. Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 2002; 39:872-5.
28. Yonova C, Valderrabano F. The influence of extracellular fluid volume on serum proteins in peritoneal dialysis patients. Minerva Urol Nefrol 2004; 56:367-9.
29. Dumler F. Hypoalbuminemia is a marker of overhydration in chronic maintenance patients on dialysis. ASAIO J 2003; 49:282-6.
30. Woodrow G, Oldroyd B, Wright A, Coward WA, Turney JH, Brownjohn AM, et al. Abnormalities of body composition in peritoneal dialysis patients. Perit Dial Int 2004; 24: 169-75.
31. Plum J, Schoenicke G, Kleophas W, Kulas W, Steffens F, Azem A, et al. Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transplant 2001; 16:2378-85.
32. Abu-Alfa AK, Burkart J, Piraino B, Pulliam J, Mujais S. Approach to fluid management in peritoneal dialysis: a practical algorithm. Kidney Int Suppl 2002; 81:S8-16.
33. Rodriguez-Carmona A, Perez-Fontan M, Garca-Naveiro R, Villaverde P, Peteiro J. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 2004; 44:132-45.
34. Tzamaloukas AH, Saddler MC, Murata GH, Malhotra D, Sena P, Simon D, et al. Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 1995; 6:198-206.
35. Frankenfield DL, Prowant BF, Flanigan MJ, Frederick PR, Bailie GR, Helgerson SD, et al. Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup. Kidney Int 1999; 55:1998-2010.
36. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994; 46:496-503.
37. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39:862-71.
38. Woodrow G, Oldroyd B, Stables G, Gibson J, Turney JH, Brownjohn AM. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis. Nephrol Dial Transplant 2000; 15:862-6.
39. Asghar RB, Green S, Engel B, Davies SJ. Relationship of demographic, dietary, and clinical factors to the hydration status of patients on peritoneal dialysis. Perit Dial Int 2004; 24:231-9.
40. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
41. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al. EAPOS Group. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: 2948-57.
42. Sharma AP, Blake PG. Should "fluid removal" be used as an adequacy target in peritoneal dialysis? Perit Dial Int 2003; 23:107-8.
43. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Mujais S. Effect of increased peritoneal clearances on mortality in peritoneal dialysis: ADEMEX, a prospective randomized controlled trial. J Am Soc Nephrol 2002; 13: 1307-20.
44. Khandelwal M, Kothari J, Krishnan M, Liakopoulos V, Tziviskou E, Sahu K, et al. Volume expansion and sodium balance in peritoneal dialysis patients. Part II: Newer insights in management. Adv Perit Dial 2003; 19:44-52.